These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Direct Comparison of Aspirin Plus Hirudin, Aspirin Plus Heparin, and Aspirin Alone Among 12,000 Patients with Acute Myocardial Infarction Not Receiving Thrombolysis: Rationale and Design of the First American Study of Infarct Survival (ASIS-1). Ridker PM; O'Donnell CJ; Hennekens CH J Thromb Thrombolysis; 1995; 1(2):119-124. PubMed ID: 10603520 [TBL] [Abstract][Full Text] [Related]
4. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy. Mahaffey KW; Granger CB; Collins R; O'Connor CM; Ohman EM; Bleich SD; Col JJ; Califf RM Am J Cardiol; 1996 Mar; 77(8):551-6. PubMed ID: 8610601 [TBL] [Abstract][Full Text] [Related]
5. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799 [TBL] [Abstract][Full Text] [Related]
6. The need for wider utilization of thrombolytic therapy. Hennekens C Clin Cardiol; 1997 Nov; 20(11 Suppl 3):III26-31. PubMed ID: 9422860 [TBL] [Abstract][Full Text] [Related]
7. Current and future perspectives on antithrombotic therapy of acute myocardial infarction. Hennekens CH; O'Donnell CJ; Ridker PM Eur Heart J; 1995 Jul; 16 Suppl D():2-9. PubMed ID: 8542867 [TBL] [Abstract][Full Text] [Related]
8. Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Menon V; Harrington RA; Hochman JS; Cannon CP; Goodman SD; Wilcox RG; Schünemann HJ; Ohman EM Chest; 2004 Sep; 126(3 Suppl):549S-575S. PubMed ID: 15383484 [TBL] [Abstract][Full Text] [Related]
9. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial. Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777 [TBL] [Abstract][Full Text] [Related]
10. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594 [TBL] [Abstract][Full Text] [Related]
11. Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction. Metz BK; Topol EJ Biomed Pharmacother; 1996; 50(6-7):243-53. PubMed ID: 8952863 [TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. White HD; Aylward PE; Frey MJ; Adgey AA; Nair R; Hillis WS; Shalev Y; Brown MA; French JK; Collins R; Maraganore J; Adelman B Circulation; 1997 Oct; 96(7):2155-61. PubMed ID: 9337184 [TBL] [Abstract][Full Text] [Related]
13. Role of aspirin with thrombolytic therapy in acute myocardial infarction. Hennekens CH Chest; 1990 Apr; 97(4 Suppl):151S-155S. PubMed ID: 2108852 [TBL] [Abstract][Full Text] [Related]
14. Is heparin of value in the management of acute myocardial infarction? White HD Cardiovasc Drugs Ther; 1997 Apr; 11(2):111-9. PubMed ID: 9140688 [TBL] [Abstract][Full Text] [Related]
15. Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy. Jafri SM; Walters BL; Borzak S J Intensive Care Med; 1995; 10(2):54-63. PubMed ID: 10172420 [TBL] [Abstract][Full Text] [Related]
16. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. GUSTO investigators N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123 [TBL] [Abstract][Full Text] [Related]
17. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. Collins R; MacMahon S; Flather M; Baigent C; Remvig L; Mortensen S; Appleby P; Godwin J; Yusuf S; Peto R BMJ; 1996 Sep; 313(7058):652-9. PubMed ID: 8811758 [TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators. Metz BK; White HD; Granger CB; Simes RJ; Armstrong PW; Hirsh J; Fuster V; MacAulay CM; Califf RM; Topol EJ J Am Coll Cardiol; 1998 Jun; 31(7):1493-8. PubMed ID: 9626825 [TBL] [Abstract][Full Text] [Related]
19. Direct thrombin inhibitors as adjuncts to thrombolytic therapy. French JK; White HD Curr Cardiol Rep; 1999 Sep; 1(3):184-91. PubMed ID: 10980840 [TBL] [Abstract][Full Text] [Related]
20. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P Chest; 2004 Sep; 126(3 Suppl):483S-512S. PubMed ID: 15383482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]